T. Rowe Price Investment Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Sell |
3,169,226
-143,223
| -4% | -$733K | 0.01% | 525 |
|
|
2025
Q1 | $4.54M | Sell |
3,312,449
-33,102
| -1% | -$45.4K | ﹤0.01% | 589 |
|
|
2024
Q4 | $10.3M | Sell |
3,345,551
-1,677,595
| -33% | -$5.18M | 0.01% | 551 |
|
|
2024
Q3 | $38.7M | Buy |
5,023,146
+267,167
| +6% | +$2.06M | 0.02% | 442 |
|
|
2024
Q2 | $40.8M | Buy |
4,755,979
+434,428
| +10% | +$3.73M | 0.03% | 420 |
|
|
2024
Q1 | $34.3M | Buy |
4,321,551
+4,034,857
| +1,407% | +$32M | 0.02% | 449 |
|
|
2023
Q4 | $2.84M | Buy |
+286,694
| New | +$2.84M | ﹤0.01% | 542 |
|